Immunology Startups in Europe

There are 15 Immunology digital health ventures in Europe. The total venture volume has expanded at a CAGR of 16.0% over the past 5 years. The ventures have an average venture maturity score of 45.4.

In total, $16.35M of digital health venture capital has been raised across 22 funding deals.

Here is a list of 10 promising HealthTech startups!

Last Updated: January 17, 2022

Ventures

Venture	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding
Ampersand Health	Digital Therapeutics	United Kingdom	$ 123.46 B	$ 123.46 B	Seed	undisclosed
Blazar	Prescriptive Analytics	France	$ 123.46 B	$ 123.46 B		undisclosed
BOOST Thyroid	Disease Management	Germany	$ 123.46 B	$ 123.46 B	Series A	undisclosed
Breakthrough Health	Disease Management	Germany	$ 123.46 B	$ 123.46 B	M&A	undisclosed
Evaxion Biotech	Drug Discovery	Denmark	$ 123.46 B	$ 123.46 B	Post-IPO Equity	$ 5.30 M
GAIA	Digital Therapeutics	Germany	$ 123.46 B	$ 123.46 B	Seed	$ 0.12 M
Hashiona	Medical Concierge	Poland	$ 123.46 B	$ 123.46 B	Seed	$ 0.54 M
Itchy	Disease Management	Sweden	$ 123.46 B	$ 123.46 B		undisclosed
Living With	Disease Management	United Kingdom	$ 123.46 B	$ 123.46 B	Grant	$ 3.86 M
Midaia	Disease Management	Germany	$ 123.46 B	$ 123.46 B	Grant	undisclosed

Showing 1 to 10 of 15 entries